Skip to main content
Fig. 3 | Journal of Experimental & Clinical Cancer Research

Fig. 3

From: Aberrant fatty acid profile and FFAR4 signaling confer endocrine resistance in breast cancer

Fig. 3

FFAR4 predicts outcome in tamoxifen-treated hormone receptor-positive breast cancer (HRPBC) patients. Kaplan-Meier curves of recurrence and breast cancer-specific deaths based on FFAR4 expression in the exploration cohort. RFS and BCSS of (a) the entire cohort (n = 307), (b) the HRPBC cohort (n = 212), (c) the hormone receptor-negative cohort (n = 95). Bottom numbers indicate patients at risk at different time points

Back to article page